About Dr. Harry Croft

Brief Overview

Medical Director, HealthyPlace.com Co-host of the HealthyPlace TV Show Medical Director, San Antonio Psychiatric Research Center Private Psychiatry Practice, The Croft Group, PA, Founded 1976, San Antonio, Texas MD from University of Texas Med. Branch, Galveston (UTMB), 1968 Partial Residency in OB-GYN at UTMB, Completed Psychiatric Residency UTMB, 1972 Board Certified in: Adult Psychiatry, Sex Therapy (AASECT), Addiction Medicine (ASAM)

• In Clinical Practice since 1976 - Principal Investigator in over 3 dozen clinical drug trials
• Over 20 publications in medical journals

CV (Partial)

Last revision: February 2010

Present Positions

Medical Director, San Antonio Psychiatric Research Center, San Antonio, Texas

Private Psychiatry Practice, The Croft Group, PA, Founded 1976, San Antonio, Texas

Work History

Private Clinical Psychiatric Practice: 1976 to present

Medical Director, SA Psychiatric Research Center

Medical Director, HealthyPlace.com: 2007-present

Co-host of the HealthyPlace TV Show: 2007-present

Education

University of Texas Medical Branch, Galveston, Texas

• 1970 - 1973 - Residency, General Psychiatry
• 1969 - 1970 - Partial Residency, Obstetrics & Gynecology
• 1964 - 1968 - MD degree

Brackenridge Hospital, Austin, Texas

• 1968 - 1969 - Internship, General Rotating

Southern Methodist University, Dallas, Texas

• 1964 - BS Degree in Biology

Certifications and Licensure

• DISTINGUISHED FELLOW, American Psychiatric Association, 2003
• FELLOW, American Psychiatric Association, 1993
• Diplomate in Psychiatry, American Board of Psychiatry & Neurology, 1979
• Certified Addictionist, American Society of Addiction Medicine, 1990
• Diplomate in Sex Therapy, American Assoc. of Sex Educators, Counselors & Therapists, 1976
• Medical License, Texas State Board of Medical Examiners, 1968, D4968

Special Training in Sexuality

• Masters & Johnson Institute, 1973
• Stan Kaplan, Ph.D., Albuquerque, New Mexico, 1972
• National Sex Forum, San Francisco, California, 1972

Membership in Professional Societies

• American Medical Association, Texas & Bexar County Branches (AMA)
• American Psychiatric Association, Texas & Bexar County Branches (APA)
• American Society of Addiction Medicine (ASAM)
• American Association of Sex Educators, Counselors & Therapists (AASECT)
• American Society for Clinical Hypnosis (ASCH)
• American Society for Clinical Psychopharmacology (ASCP)
• Titus Harris Psychiatry Society
• National Medical Speakers Association (NSA)
• National Association of Physician Broadcasters (NAPB)
• American Academy of Radio and Television Health Communicators
• Society for the Scientific Study of Sexuality (SSSS)
• International Society for the Study of Women's Sexual Health (ISSWSH)

Academic, Teaching Experience

• CME Faculty: Medical World Conferences, Duke PsychCME, Primary Care Network, Center for Medical Knowledge, Intellyst, Medical Knowledge (Psych Update, and PriMed) (To Present)
• Teaching Consultant, USAF Psychiatry Training Program, Wilford Hall Medical Center, 1973 - 1976
• Clinical Assistant Professor, Psychiatry & OB-GYN, University of Texas Health Science Center at San Antonio, 1973 - 1976
• Assistant Professor, Health Science, Baylor University, Waco, Texas, 1975 - 1976
• Instructor, Academy of Health Sciences, Fort Sam Houston, Texas, 1973 - 1976

Honors

• Recipient of Physician's Recognition Award, AMA
• Recipient of The Meritorious Service Medal, U.S. Army
• Recipient of Special President's Award, The American Psychiatric Association, 1991
• Recipient of THE WELBY AWARD FOR MEDIA EXCELLENCE, The Academy of Radio and TV Health Communicators
• Recipient of The Jules Bergman Award (BROADCASTER OF THE YEAR), The National Association of Physician Broadcasters, 1995
• Recipient of Media Award, The American Psychiatric Association, 1996
• Recipient of NATIONAL MEDIA AWARD, The National Mental Health Association, 1996
• Heart Survivor Honoree, The American Heart Association, 2003
• Biography: Who's Who in America (since 1976), Who's Who in Professional Speaking

Papers, Posters, Presentations

• Croft,H, Montejo,AL, Salazar-Fraile,J. "Bupropion: Tolerability and Safety," Actas Esp Psiquiatr (SPAIN) 2008:36 (Supp 4).
• Nurnberg, GN, Hensley, PJ, Croft, HA, Debattista, CA, et al "Sildenafil Treatment of Women with Antidepressant-Associated Sexual Dysfunction: A Randomized Clinical Trial," JAMA, July 23/30, 2008 (Vol 300): No 4, 395-404
• Seagraves, Clayton, Croft, et al "A Multicenter Double Blind Placebo Controlled Study of Bupropion XL in Females with Orgasm Disorders" Poster at Psychiatric Congress 06, New Orleans, 11/06.
• Croft,HA "Physician Handling of Prescription Stimulants (CME Article)", Pediatric Annals 35:8, 557-562, August, 2006.
• Clayton, A, Croft HA et al, "Bupropion XL Compared with Escitalopram: Effects on Sexual Functioning and Antidepressant Efficacy in Two Randomized, Double-Blind, Randomized Clinical Studies", Journal of Clinical Psychiatry 67:5 735-746, May, 2006.
• Croft, HA "Physician Handling of Prescription Stimulants (CME Article)" Psychiatric Annals 35:3 221-226 2005.
• Wornock JK, Clayton AH, Croft HA, Segraves RT, Biggs CF. "Comparison Of Androgens IWomen With Hypoactive Sexual Desire Disorder: Combined Oral Contraceptive Pill Users vs NoCombined Oral Contraceptive Pill Users." Oral presentation at the International Society for The Study of Women's Sexual Health (ISSWSH) Annual Meeting, Atlanta, GA, October 28-31, 2004. Journal of Sex & Marital Therapy (In Print, 06)
• Seagraves, RT, Clayton, A, Croft, HA et al, "Bupropion Sustained Release for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women," J Clin Psychopharmacology; 2004, 243) 339-342.
• Seagraves, RT, Clayton, A, Croft, HA et al, "Multicenter Study of Bupropion in Female Hypoactive Sexual Desire Disorder," Presented at 2003 Annual Meeting of the International Society for the Study of Women's Sexual Health, Amsterdam, the Netherlands. October, 2003.
• Labbate, L, Croft,HA, and Oleshansky, MA, "Antidepressant-Related Erectile Dysfunction: Management via Avoidance, Switching Antidepressants, Antidotes, and Adaptation," J Clin Psychiatry, 2003; 64 (10): 11-19.

• Clayton, A, Pradko, J, Croft, HA, et al. "Prevalence of Sexual Dysfunction Among Newer Antidepressants," J Clin Psychiatry, 2002; 63 (4): 357-366

• Nurnberg H, Hensley P, Fava M, Croft HA, Gelenberg A, Wornock J, Shabsogh R, "Sildenafil for Serotonin Reuptake Inhibitor-Antidepressant Associated Female Sexual Dysfunction," Presented at New Clinical Drug Evaluation Unit (NCDEU) annual meeting, Boca Raton, 2002

• Croft, HA, Houser, T, Jamerson B, Leadbetter R, "Effect on Body Weight of Bupropion SR in Patients with Major Depression Treated for 52 weeks," Clinical Therapeutics,24(4),April 2002

• Seagraves, R.T., Croft, H.A., Kavoussi, R., Ascher, J., Batey, S., et al. "Bupropion sustained release for the treatment of hypoactive sexual desire disorder in nondepressed women." Journal of Sex and Marital Therapy, 2001; 27 (3) : 301-316

• Croft, HA, "The Patient with Depression: Managing Compliance and Side Effects" Profiles in Depression, (Oxford Institute for Continuing Education), March 2002

• Seagraves, R.T., Croft, H.A., Kavoussi, R., Ascher, J., Batey, S., et al. "Bupropion sustained release for the treatment of hypoactive sexual desire disorder in nondepressed women," Journal of Sex and Marital Therapy, 27(3): 303-316. 2001 May-June

• Croft, HA Settle, E, Houser T Batey, SR et al. "A Placebo Controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline," Clinical Therapeutics, 21(4): 643-658, 1999 April

• Croft HA, Asher J, Batey S et al. "A comparison of burprion SR, Sertraline and placebo in depressed outpatients," Biological Psychiatry, 45(8 supp) 75s, 1999

• Croft H, Houser T Leadbetter R, Jamerson B, Metz A. Effects of bupropion sr on weight in the long-term treatment of depression. Obesity Research, 8 (Suppl. 1:10S), 2000

• Croft H, Houser TL, Leadbetter R, Jamerson B, Metz A. Effects of bupropion sr on weight in the long term treatment of depression. Biological Psychiatry 49(Suppl 8:36s) 2001

• Croft, H.A., Batey, S., Ascher, J., et al. "A Comparison of the Effects of Bupropion SR and Sertraline on Sexual Functioning in Depressed Outpatients", Poster Presented at Annual Meetings of: American Society of Clinical Psychopharmacology, St. Thomas, Virgin Islands, February 1999; Society of Biological Psychiatry, Washington, DC, May 1999; The American Psychiatric Association, Washington, DC, May 1999, European College of Neuropsychopharmacology, London, UK, September 1999

• Kaats, G.R., Keith, S.C., Croft, H.A., Pullin, D., Squires, W., Wise, J.A. "Dietary Supplements and Behavior Modification Plan to Improve the Safety and Efficacy of Pharmacotherapy", Advances in Therapy, 1998; 15: 165-177

• Kaats, G.R., Wise, J.A., Blum, K., Morin, R.J., Adelman, J.A., Craig, J., Croft, H.A. "The Short -Term Therapeutic Efficacy of Treating Obesity with a Plan of Improved Nutrition and Moderate Caloric Restriction", Current Therapeutic Research, 1996; 51: 261-274

• Szekely, B. & Croft, H.A. "Effect of Naproxen Sodium on Perimenstrual Headache and Other Perimenstrual Symptoms: A Double -Blind, Placebo Controlled Study," American Journal of Gynecologic Health, Vol.V, #4,July/August 1991

• Szekely, B. & Croft, H.A. "Prophylactic Effects of Naproxen Sodium on Perimenstrual Headache," Cephalalgia, International Journal of Headache, Vol. 19, Supp. 10, 1989

• Szekely, B. & Croft, H.A. "Descriptive Characteristics of Women with Perimenstrual Headache," Headache, The Journal of Head & Face Pain, Vol. 29, #5, 1989

• Levinson, A.J. & Croft, H.A. "Patients' Sexual Problems-Aspects of Physicians' Qualifications & Management," The Journal of Reproductive Medicine, Vol. 18, #1, January 1977

• Croft, H.A. "How to Refer Your Patients to a Psychiatrist Without Hurting Their Feelings," Resident & Staff Physician Medical Times, August, 1976

• Croft, H.A. "Managing Common Sexual Problems," Post Graduate Medicine, 4 Part Series, 1976: "Sexual History Taking," Vol. 60, #3, Sep. 1976., "Causes of Sexual Dysfunction," Vol. 60, #4, Oct.1976., "A Multilevel Treatment Model - Levels 1 & 2," Vol. 60, #5, Nov. 1976., "A Multilevel Treatment Model - Levels 3 & 4," Vol. 60, #6, Dec. 1976

Research

Between 1984-2008, Dr. Croft has conducted and participated in nearly 50 studies and clinical trials for major pharmaceutical companies for medications primarily focused on depression and anxiety disorders.  These pharmaceutical companies include: Forest Laboratories, Sepracor, Bristol-Myers Squibb, Astrazeneca, Sanofi-Aventis, GlaxoSmithKline, Eli Lilly, Merck, Pharmacia & Upjohn, Pfizer, Novartis, and others.

Major Workshops and Presentations

• The American Medical Association
• The American Psychiatric Association
• The American Society of Clinical Psychopharmacology
• The European College of Neuropsychopharmacology
• The Society of Biological Psychiatry
• The National Society for the Scientific Study of Obesity
• The American College of Obstetrics & Gynecology
• The American Association of Marriage & Family Counselors
• The Southern Medical Association
• The Texas Medical Association
• The National Army Chaplain's Association
• The National Army Social Work Association
• Retail Pharmacists of America
• The American Farm Bureau
• Jewish Women's International Conferences
• Lectures Given to Psychiatrists, Primary Care Physicians, Neurologists, Mental Health Professionals, OB-Gyns, and other professional groups in: ALL OF THE 50 United States, London, Paris, Amsterdam, San Juan, St Thomas, Monterrey, Toronto, Madrid.
• Member of Distinguished Faculty for the following CME providers: PsychCME (Duke Psychiatry), Primary Care Network(PCN), Medical World Conferences, Prime MD Net, Texas Association of Family Practice Curriculum Development: Primary Care Network

Lecture Topics (Physicians and Mental Health Professionals)

• Managing Unipolar to Bipolar Depression Spectrum
• Depression-Long Term Treatment and Challenges
• Advances in Antidepressant Treatment
• Evaluation and Treatment of Adult ADHD
• Treatment of Anxiety Disorders
• Alcohol and Drug Abuse and Dependence Disorders
• Treatment of Medication Induced Sexual Dysfunction
• Treatment of Erectile Dysfunction
• Female Sexual Health
• Management of Insomnia

Full Disclosure Information (as of February 1, 2009)

RESEARCH GRANTS to Croft Group Research Center

• Boehringer-Ingelheim
• Bristol-Myers-Squibb
• Cephalon
• Forest Laboratories
• GlaxoSmithKline
• Eli Lilly
• Merck
• Organon
• Pfizer
• Sanofi-Aventis
• Takeda

SPEAKING HONORARIA (2004-2011):

• Astrazeneca
• Bristol-Myers-Squibb
• Forest Laboratories
• GlaxoSmithKline
• Eli Lilly
• Pfizer
• Sanofi-Aventis
• Wyeth

CONSULTANT (2004-2008):

• Forest Laboratories
• GlaxoSmithKline
• Eli Lilly
• Pfizer

ADVISORY BOARD (2004-2008):

• GlaxoSmithKline
• Eli Lilly
• Pfizer

OTHER FINANCIAL INTEREST (or Family):

• None

Mental health articles on HealthyPlace by Dr. Croft.

next: More about Dr. Harry Croft